(Q45760540)

15 December 2017

title

Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers--infection by needle sharing? (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

Grinde B

1

1 reference

15 December 2017

Stene-Johansen K

2

1 reference

15 December 2017

Sharma B

3

1 reference

15 December 2017

Hoel T

4

1 reference

15 December 2017

Jensenius M

5

1 reference

15 December 2017

Skaug K

6

1 reference

15 December 2017

publication date

1 September 1997

1 reference

15 December 2017

Journal of Medical Virology

published in

1 reference

15 December 2017

volume

53

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

69-75

1 reference

15 December 2017

Hepatitis A transmission by factor IX concentrates

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Genetic, antigenic and biological differences between strains of hepatitis A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Detection of hepatitis A virus in clinical and environmental samples by immunomagnetic separation and PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Interruption of an outbreak of hepatitis A in two villages by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199709%2953%3A1%3C69%3A%3AAID-JMV12%3E3.0.CO%3B2-S

10.1002/(SICI)1096-9071(199709)53:1<69::AID-JMV12>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017